Ionis Pharmaceuticals (IONS) Tops Q3 EPS by 17c

Ionis Pharmaceuticals (NASDAQ: IONS) reported Q3 EPS of ($0.95), $0.17 better than the analyst estimate of ($1.12). Revenue for the quarter came in at $134 million versus the consensus estimate of $129.33 million.

For earnings history and earnings-related data on Ionis Pharmaceuticals (IONS) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• BuzzFeed sells shares to Byron Allen affiliate for $5.8 million
• ZenaTech raises Plurilock Security stake to 12% with new share purchase